The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib
Clinical trial NCT03528941 · COMPLETED
Trial details
- NCT number
- NCT03528941
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-11-28
- Primary completion
- 2021-03-26
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.